Slc7a11 stimulates glutathione synthesis to preserve fatty acid metabolism in primary hepatocytes

References

• Ogoke O, Oluwole J, Parashurama N. Bioengineering considerations in liver regenerative medicine. J Biol Eng. 2017;11:46.
   PubMed Web of Science ®Google Scholar
• Gomez-Lechon MJ, Donato MT, Castell JV, et al. Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab. 2003 Aug;4(4):292–312.
   PubMed Web of Science ®Google Scholar
• Wilkening S, Stahl F, Bader A. Comparison of primary human hepatocytes and hepatoma cell line Hepg2 with regard to their biotransformation properties. Drug Metab Dispos. 2003 Aug;31(8):1035–1042.
   PubMed Web of Science ®Google Scholar
• Andersson TB, Kanebratt KP, Kenna JG. The HepaRG cell line: a unique in vitro tool for understanding drug metabolism and toxicology in human. Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):909–920.
   PubMed Web of Science ®Google Scholar
• Samanez CH, Caron S, Briand O, et al. The human hepatocyte cell lines IHH and HepaRG: models to study glucose, lipid and lipoprotein metabolism. Arch Physiol Biochem. 2012 Jul;118(3):102–111.
   PubMed Web of Science ®Google Scholar
• Gerbal-Chaloin S, Funakoshi N, Caillaud A, et al. Human induced pluripotent stem cells in hepatology: beyond the proof of concept. Am J Pathol. 2014 Feb;184(2):332–347.
   PubMed Web of Science ®Google Scholar
• Bell CC, Lauschke VM, Vorrink SU, et al. Transcriptional, functional, and mechanistic comparisons of stem cell-derived hepatocytes, HepaRG cells, and three-dimensional human hepatocyte spheroids as predictive In vitro systems for drug-induced liver injury. Drug Metab Dispos. 2017 Apr;45(4):419–429.
   PubMed Web of Science ®Google Scholar
• Godoy P, Hewitt NJ, Albrecht U, et al. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol. 2013 Aug;87(8):1315–1530.
   PubMed Web of Science ®Google Scholar
• Fraczek J, Bolleyn J, Vanhaecke T, et al. Primary hepatocyte cultures for pharmaco-toxicological studies: at the busy crossroad of various anti-dedifferentiation strategies. Arch Toxicol. 2013 Apr;87(4):577–610.
   PubMed Web of Science ®Google Scholar
• Papeleu P, Loyer P, Vanhaecke T, et al. Proliferation of epidermal growth factor-stimulated hepatocytes in a hormonally defined serum-free medium. Altern Lab Anim. 2004 Jun;32(Suppl 1A):57–64.
   PubMedGoogle Scholar
• Elaut G, Henkens T, Papeleu P, et al. Molecular mechanisms underlying the dedifferentiation process of isolated hepatocytes and their cultures. Curr Drug Metab. 2006 Aug;7(6):629–660.
   PubMed Web of Science ®Google Scholar
• Baker TK, Carfagna MA, Gao H, et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. Chem Res Toxicol. 2001 Sep;14(9):1218–1231.
   PubMed Web of Science ®Google Scholar
• de Longueville F, Atienzar FA, Marcq L, et al. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol Sci. 2003 Oct;75(2):378–392.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Antona C, Donato MT, Boobis A, et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells. Xenobiotica. 2002 Jun;32(6):505–520.
   PubMed Web of Science ®Google Scholar
• Beigel J, Fella K, Kramer PJ, et al. Genomics and proteomics analysis of cultured primary rat hepatocytes. Toxicol Vitro. 2008 Feb;22(1):171–181.
   PubMed Web of Science ®Google Scholar
• Heslop JA, Rowe C, Walsh J, et al. Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile. Arch Toxicol. 2017 Jan;91(1):439–452.
   PubMed Web of Science ®Google Scholar
• Matsuno F, Chowdhury S, Gotoh T, et al. Induction of the C/EBP beta gene by dexamethasone and glucagon in primary-cultured rat hepatocytes. J Biochem. 1996 Mar;119(3):524–532.
   PubMed Web of Science ®Google Scholar
• Yamada S, Otto PS, Kennedy DL, et al. The effects of dexamethasone on metabolic activity of hepatocytes in primary monolayer culture. In Vitro. 1980 Jul;16(7):559–570.
   PubMedGoogle Scholar
• Bell CC, Dankers ACA, Lauschke VM, et al. Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: a multicenter study. Toxicol Sci. 2018 Apr 1;162(2):655–666.
   PubMed Web of Science ®Google Scholar
• Lauschke VM, Shafagh RZ, Hendriks DFG, et al. 3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism, and toxicity: emerging culture paradigms and applications. Biotechnol J. 2019 Jul;14(7):e1800347.
   PubMed Web of Science ®Google Scholar
• Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem. 1986 Feb 15;261(5):2256–2263.
   PubMed Web of Science ®Google Scholar
• Sato H, Tamba M, Ishii T, et al. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 1999 Apr 23;274(17):11455–8.
   PubMed Web of Science ®Google Scholar
• Nakamura E, Sato M, Yang H, et al. 4F2 (CD98) heavy chain is associated covalently with an amino acid transporter and controls intracellular trafficking and membrane topology of 4F2 heterodimer. J Biol Chem. 1999 Jan 29;274(5):3009–3016.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhang Y, Zhuang L, et al. Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer. Cancer Commun (Lond). 2018 Apr 25;38(1):12.
   PubMed Web of Science ®Google Scholar
• Lewerenz J, Hewett SJ, Huang Y, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013 Feb 10;18(5):522–555.
   PubMed Web of Science ®Google Scholar
• Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021 Aug;12(8):599–620.
   PubMed Web of Science ®Google Scholar
• Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Mol Aspects Med. 2009 Feb-Apr;30(1-2):1–12.
   PubMed Web of Science ®Google Scholar
• Vaskova J, Kocan L, Vasko L, et al. Glutathione-Related enzymes and proteins: A review. Molecules. 2023 Feb 2;28(3):1447.
   PubMed Web of Science ®Google Scholar
• Chen Y, Dong H, Thompson DC, et al. Glutathione defense mechanism in liver injury: insights from animal models. Food Chem Toxicol. 2013 Oct;60:38–44.
   PubMed Web of Science ®Google Scholar
• Liu T, Sun L, Zhang Y, et al. Imbalanced GSH/ROS and sequential cell death. J Biochem Mol Toxicol. 2022 Jan;36(1):e22942.
   PubMed Web of Science ®Google Scholar
• Yuan L, Kaplowitz N. Glutathione in liver diseases and hepatotoxicity. Mol Aspects Med. 2009 Feb-Apr;30(1-2):29–41.
   PubMed Web of Science ®Google Scholar
• Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against Acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology. 2010 Jan;51(1):246–254.
   PubMed Web of Science ®Google Scholar
• Irie M, Sohda T, Anan A, et al. Reduced glutathione suppresses oxidative stress in nonalcoholic fatty liver disease. Euroasian J Hepatogastroenterol. 2016 Jan-Jun;6(1):13–18.
   PubMedGoogle Scholar
• Hajighasem A, Farzanegi P, Mazaheri Z. Effects of combined therapy with resveratrol, continuous and interval exercises on apoptosis, oxidative stress, and inflammatory biomarkers in the liver of old rats with non-alcoholic fatty liver disease. Arch Physiol Biochem. 2019 May;125(2):142–149.
   PubMed Web of Science ®Google Scholar
• Ursini F, Maiorino M. Lipid peroxidation and ferroptosis: the role of GSH and GPx4. Free Radic Biol Med. 2020 May 20;152:175–185.
   PubMed Web of Science ®Google Scholar
• Lin J, Wu PH, Tarr PT, et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell. 2004 Oct 1;119(1):121–135.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013 Jan 1;29(1):15–21.
   PubMed Web of Science ®Google Scholar
• Anders S, Pyl PT, Huber W. HTSeq–a python framework to work with high-throughput sequencing data. Bioinformatics. 2015 Jan 15;31(2):166–169.
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
   PubMed Web of Science ®Google Scholar